Given the absence of a discernible M-protein on SIFE, with a small κ restriction on UIFE and a polyclonal increase in κ SFLCs, the patient’s condition is currently being managed as an oligosecretory MM. The gene discussed is MYOM2; the disease is Miyoshi myopathy.